|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Erratum: Vol. 45, No. RR-7The MMWR Recommendations and Reports, "Prevention of Perinatal Group B Streptococcal Disease: A Public Health Perspective," contained two errors. Page 17, Box 1: Item 3 should read: 3. Remove the swabs from the transport medium and inoculate both swabs together into selective broth medium. Todd-Hewitt broth supplemented with either colistin (10 ug/mL) and nalidixic acid (15 ug/mL) or with gentamicin (8 ug/mL) and nalidixic acid (15 ug/mL) may be used; appropriate commercially available options include Lim or SBM broth. Page 20: Figure_3 contained an arrow pointing in the incorrect direction. The corrected Figure_3E appears below. Figure_3 Return to top. Figure_3E Return to top. Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 09/19/98 |
|||||||||
This page last reviewed 5/2/01
|